Close Menu

Open access data will soon require business models, says Deepak Singh at bbgm. And he's not the only one to believe this, as he points out several posts that speak to putting open data into a useable (and accessible) framework as being key to building upon it. The best way to do this, of course, is to set up a business and charge a fee. Re-iterates Singh, "Data, especially open data, needs to be accompanied by APIs that allow the data to be accessed in a number of formats.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.